Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 28.4B | 33.5B | 29.4B | 28.6B |
Cost of revenue | 17.5B | 21.5B | 21.1B | 19.7B |
Gross profit | 10.9B | 12.0B | 8.3B | 8.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.3B | 4.5B | 4.0B | 3.9B |
Operating income | 2.9B | 3.9B | 803.2M | 1.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 425.5M | 427.7M | 384.4M | 290.6M |
Other income expense | — | — | — | — |
Pretax income | 2.7B | 3.9B | 957.7M | 1.6B |
Tax provision | 908.8M | 1.2B | 328.5M | 580.3M |
Net income | 1.8B | 2.6B | 629.2M | 1.0B |
Basic EPS | — | 16.8 | 4.0 | 6.4 |
Diluted EPS | — | 16.8 | 4.0 | 6.4 |
Basic average shares | — | 155.9M | 155.7M | 156.0M |
Diluted average shares | — | 155.9M | 155.7M | 156.0M |
EBITDA | 4.3B | 5.4B | 2.4B | 2.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |